top of page


European Commission launches eligibility checker for EU Joint Clinical Assessments
The new tool is intended to help health technology developers determine whether a medicinal product falls within the EU’s Joint Clinical Assessment requirements before entering the formal HTA process.

nuaxia
Aug 123 min read


EU Joint Clinical Assessment enters second year as pharmaceutical companies adapt evidence strategies
The EU Health Technology Assessment Regulation now requires eligible oncology medicines and advanced therapies to undergo a single European clinical assessment, increasing the importance of early evidence planning alongside EMA regulatory development.

nuaxia
Aug 113 min read
bottom of page